BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3166276)

  • 21. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
    Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
    Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative studies of DL-8280 and pipemidic acid in complicated urinary tract infections by double-blind method].
    Kishi H; Nito H; Saito I; Nishimura Y; Niijima T; Ohmori H; Tanaka H; Fujita Y; Deguchi K; Ogawa N
    Hinyokika Kiyo; 1984 Sep; 30(9):1307-55. PubMed ID: 6395684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of urinary tract infection caused by Flavimonas oryzihabitans].
    Topkaya AE; Ozakkaş F; Aksungar FB; Tülbek Y
    Mikrobiyol Bul; 2007 Jan; 41(1):133-7. PubMed ID: 17427563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antibiotic resistance and antibiotic utilization in urinary tract infections in 11 family practices in Maastricht].
    Stobberingh EE; Houben AW
    Ned Tijdschr Geneeskd; 1988 Sep; 132(39):1793-7. PubMed ID: 3263577
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effectiveness of levofloxacin (Tavanik, "Aventis Pharma") in the treatment of complicated infections of the urogenital organs].
    Derevianko II; Lavrinova LN; Kudriashova EE
    Urologiia; 2003; (1):31-4. PubMed ID: 12621964
    [No Abstract]   [Full Text] [Related]  

  • 26. [Sensitivity to antibiotics of 2081 bacterial strains isolated from urinary tract infections. Critical study and treatment suggestions].
    Roupas A; Piguet JD
    Schweiz Med Wochenschr; 1968 Dec; 98(51):2008-16. PubMed ID: 5728699
    [No Abstract]   [Full Text] [Related]  

  • 27. Regional community-acquired urinary tract infections in Israel: diagnosis, pathogens, and antibiotic guidelines adherence: a prospective study.
    Nesher L; Novack V; Riesenberg K; Schlaeffer F
    Int J Infect Dis; 2007 May; 11(3):245-50. PubMed ID: 16891141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of bacterial infections by ofloxacin. 42 cases].
    Chavanet P; Arnould S; Sarret Y; Caillot D; Solary E; Portier H
    Pathol Biol (Paris); 1987 May; 35(5):620-3. PubMed ID: 3302870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bacteriological diagnosis and aimed drug therapy of urinary tract infections].
    Roser H
    Med Welt; 1970 Sep; 39():1711-3. PubMed ID: 5510257
    [No Abstract]   [Full Text] [Related]  

  • 30. [Carbenicillin in the therapy of urinary infections by gram-negative bacteria].
    De Rosa F; Di Nardo V; Lotti T
    Clin Ter; 1970 Nov; 55(4):339-43. PubMed ID: 5516890
    [No Abstract]   [Full Text] [Related]  

  • 31. [Production of a stable nitrofurantoin solution and experience with its use in urological practice].
    Futaki Z; Simon FJ; Regdon G
    Orv Hetil; 1988 Mar; 129(11):563-6. PubMed ID: 3362544
    [No Abstract]   [Full Text] [Related]  

  • 32. [The management of urinary tract infections with CN-3123. Experience with gynecologic patients and women in childbirth].
    Feltmann K
    Ther Ggw; 1976 May; 115(5):896-905. PubMed ID: 960028
    [No Abstract]   [Full Text] [Related]  

  • 33. Enoxacin for the treatment of urinary tract infection.
    Bailey RR; Peddie BA
    N Z Med J; 1985 Apr; 98(777):286-8. PubMed ID: 3857511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Empirical treatment of urinary tract infections.
    Leibovici L
    Isr Med Assoc J; 2000 Oct; 2(10):804-5. PubMed ID: 11344744
    [No Abstract]   [Full Text] [Related]  

  • 35. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology].
    Derevianko II; Lopatkin NA; Khodyreva LA; Kondrat'eva EM
    Urol Nefrol (Mosk); 1998; (5):14-8. PubMed ID: 9820038
    [No Abstract]   [Full Text] [Related]  

  • 36. Antimicrobial sensitivity patterns as a guide to the domiciliary treatment of urinary tract infections.
    Hunter IJ
    Med J Aust; 1972 Feb; 1(9):442. PubMed ID: 5024406
    [No Abstract]   [Full Text] [Related]  

  • 37. [Chronic urinary tract infection and treatment with Nibiol].
    von Rütte B; Delnon I
    Schweiz Med Wochenschr; 1968 Nov; 98(47):1864-8. PubMed ID: 5704712
    [No Abstract]   [Full Text] [Related]  

  • 38. [Ofloxacin (RU 43280). Clinical study].
    Bertrand A; Janbon F; Despaux E; Jonquet O; Reynes J
    Pathol Biol (Paris); 1987 May; 35(5):629-33. PubMed ID: 3302873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ofloxacin treatment in nephrologic problem patients with various degrees of chronic renal failure (including dialysis treatment). Preliminary results].
    Schulz W; Dörfler A
    Infection; 1986; 14 Suppl 1():S97-101. PubMed ID: 3456988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term treatment and clinical evaluation of enoxacin in complicated urinary tract infections].
    Washida H; Sakagami H; Iwase Y; Sasaki S
    Hinyokika Kiyo; 1987 Sep; 33(9):1508-12. PubMed ID: 3481218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.